Home › Multiple Sclerosis
Pag-aaral pangklinika para sa Multiple Sclerosis na nagre-recruit sa U.S.
132 pag-aaral para sa Multiple Sclerosis ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY17 pag-aaral
- Chicago, IL15 pag-aaral
- Boston, MA14 pag-aaral
- Washington, DC13 pag-aaral
- Cleveland, OH10 pag-aaral
- Birmingham, AL9 pag-aaral
- Aurora, CO8 pag-aaral
- Kansas City, KS8 pag-aaral
- St. Louis, MO8 pag-aaral
- San Francisco, CA8 pag-aaral
- Tampa, FL7 pag-aaral
- Dallas, TX7 pag-aaral
- Columbus, OH7 pag-aaral
- Atlanta, GA7 pag-aaral
- Milwaukee, WI7 pag-aaral
- Baltimore, MD7 pag-aaral
- Seattle, WA7 pag-aaral
- Farmington Hills, MI6 pag-aaral
- Houston, TX6 pag-aaral
- Naples, FL5 pag-aaral
- Austin, TX5 pag-aaral
- Brockton, MA5 pag-aaral
- San Diego, CA5 pag-aaral
- Raleigh, NC4 pag-aaral
- Ann Arbor, MI4 pag-aaral
- Gainesville, FL4 pag-aaral
- Orlando, FL4 pag-aaral
- Scottsdale, AZ4 pag-aaral
- Champaign, IL4 pag-aaral
- Miami, FL4 pag-aaral
- Knoxville, TN4 pag-aaral
- Philadelphia, PA4 pag-aaral
- Mountain View, CA4 pag-aaral
- New Haven, CT4 pag-aaral
- Durham, NC4 pag-aaral
- Oklahoma City, OK3 pag-aaral
- Kirkland, WA3 pag-aaral
- Fort Collins, CO3 pag-aaral
- Honolulu, HI3 pag-aaral
- Sandy Springs, GA3 pag-aaral
Ayos sa estado
- Alabama9 pag-aaral
- Arizona6 pag-aaral
- California24 pag-aaral
- Colorado12 pag-aaral
- Connecticut6 pag-aaral
- District of Columbia4 pag-aaral
- Florida16 pag-aaral
- Georgia8 pag-aaral
- Hawaii3 pag-aaral
- Illinois19 pag-aaral
- Kansas9 pag-aaral
- Kentucky3 pag-aaral
- Maryland17 pag-aaral
- Massachusetts19 pag-aaral
- Michigan10 pag-aaral
- Minnesota4 pag-aaral
- Missouri8 pag-aaral
- Nebraska3 pag-aaral
- New Jersey11 pag-aaral
- New York20 pag-aaral
- North Carolina9 pag-aaral
- Ohio15 pag-aaral
- Oklahoma4 pag-aaral
- Pennsylvania8 pag-aaral
- Tennessee6 pag-aaral
- Texas18 pag-aaral
- Utah3 pag-aaral
- Virginia3 pag-aaral
- Washington10 pag-aaral
- Wisconsin8 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Skeletal Muscle Aging and Responsiveness in Aged People With MS
Nagre-recruit
Edad 60 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07500727Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03816345Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
1 Month – 99 Years · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00794352Investigating the Impact of Treadmill-integrated Virtual Reality Training on Walking Outside the Clinic
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07927439Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Nagre-recruitPhase 2
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07497399RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07002034Kesimpta (Ofatumumab) Pregnancy Registry
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT05634967Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
Nagre-recruitPhase 2
Edad 55 hanggang 75 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06463743Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis
Nagre-recruitPhase 3
Edad 25 hanggang 75 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06136728Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
Nagre-recruit
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07376772HOBSCOTCH-MS-Efficacy Trial
Nagre-recruit
Edad 20 hanggang 75 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT06951919Understanding and Enhancing Human Health and Movement
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07738978A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07840326A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06433752A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Nagre-recruitPhase 4
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07609719Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 120 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT01730131Dry Needling in Multiple Sclerosis
Nagre-recruit
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT07615725A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
Nagre-recruitObservasyonal na pag-aaral
Edad 15 hanggang 50 · Kababaihan · Na-update Okt 29, 2026 · NCT06433765Efgartigimod for the Treatment of Acute Optic Neuritis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06453694A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06782490A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06680037iConquerMS™ - A Patient-Powered Research Network for Multiple Sclerosis
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT02486562Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT00001248Care in Multiple Sclerosis (MS)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 29 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07011914Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT06495138Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.